K-Group Beta Report issue

For profit Phase 1 Phase 2
Founded: San Diego California United States (2019)

Organization Overview

First Clinical Trial
2019
NCT04158336
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

K-Group Alpha | K-Group Alpha, Inc. | K-Group Beta